Syndax Pharmaceuticals (SNDX) PT Lowered to $43 at Mizuho

March 30, 2026 8:57 AM

Mizuho analyst Salim Syed lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $43.00 (from $45.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found